文献速递临床试验与 GCP流行病学与生物统计

结肠镜外展与粪便免疫化学检测外展对结直肠癌筛查完成率的影响:一项随机临床试验

Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2017-01-01

在安全网医疗机构接受初级保健的50至64岁人群中,邮寄结肠镜外展、邮寄粪便免疫化学检测(FIT)外展与常规护理相比,均提高了3年内结直肠癌筛查流程完成率;结肠镜外展组完成率高于FIT外展组。

要点

  • 结肠镜外展组筛查流程完成率为38.4%,FIT外展组为28.0%,常规护理组为10.7%。
  • 与常规护理相比,结肠镜外展组完成率提高27.7%(95%CI 25.1%至30.4%),FIT外展组提高17.3%(95%CI 14.8%至19.8%)。
  • 结肠镜外展组较FIT外展组完成率提高10.4%(95%CI 7.8%至13.1%),P<.001。

核心结论

  • 在50至64岁于安全网机构接受初级保健的人群中,与常规护理相比,邮寄FIT或结肠镜外展邀请均提高了3年内结直肠癌筛查流程完成比例;结肠镜外展的筛查流程完成率高于FIT外展。

研究设计与样本

  • 实用随机临床试验,2013年3月至2016年7月纳入5999名50至64岁、在Parkland Health and Hospital System接受初级保健且未及时进行结直肠癌筛查的参与者。
  • 参与者随机分为邮寄FIT外展组(n=2400)、邮寄结肠镜外展组(n=2400)或常规护理加诊所筛查组(n=1199)。

主要发现

  • 筛查流程完成率:结肠镜外展组38.4%,FIT外展组28.0%,常规护理组10.7%。
  • 与常规护理组相比,完成率的组间差异:结肠镜外展组27.7%(95%CI 25.1%至30.4%),FIT外展组17.3%(95%CI 14.8%至19.8%);结肠镜外展组较FIT外展组高10.4%(95%CI 7.8%至13.1%),所有比较P<.001。
  • 与常规护理相比,腺瘤和进展期肿瘤检出率的组间差异:结肠镜外展组腺瘤10.3%(95%CI 9.5%至12.1%)、进展期肿瘤3.1%(95%CI 2.0%至4.1%),两者P<.001;FIT外展组腺瘤1.3%(95%CI -0.1%至2.8%)、进展期肿瘤0.7%(95%CI -0.2%至1.6%),P值分别为P<.08和P<.13。
  • 结肠镜外展组与FIT外展组相比:腺瘤检出率差异9.0%(95%CI 7.3%至10.7%),进展期肿瘤检出率差异2.4%(95%CI 1.3%至3.3%),两者P<.001。
  • 所有组均无筛查相关伤害。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Mailed fecal immunochemical test (FIT) outreach is more effective than colonoscopy outreach for increasing 1-time colorectal cancer (CRC) screening, but long-term effectiveness may need repeat testing and timely follow-up for abnormal results. OBJECTIVE: Compare the effectiveness of FIT outreach and colonoscopy outreach to increase completion of the CRC screening process (screening initiation and follow-up) within 3 years. DESIGN, SETTING, AND PARTICIPANTS: Pragmatic randomized clinical trial from March 2013 to July 2016 among 5999 participants aged 50 to 64 years who were receiving primary care in Parkland Health and Hospital System and were not up to date with CRC screenings. INTERVENTIONS: Random assignment to mailed FIT outreach (n = 2400), mailed colonoscopy outreach (n = 2400), or usual care with clinic-based screening (n = 1199). Outreach included processes to promote repeat annual testing for individuals in the FIT outreach group with normal results and completion of diagnostic and screening colonoscopy for those with an abnormal FIT result or assigned to colonoscopy outreach. MAIN OUTCOMES AND MEASURES: Primary outcome was screening process completion, defined as adherence to colonoscopy completion, annual testing for a normal FIT result, diagnostic colonoscopy for an abnormal FIT result, or treatment evaluation if CRC was detected. Secondary outcomes included detection of any adenoma or advanced neoplasia (including CRC) and screening-related harms (including bleeding or perforation). RESULTS: All 5999 participants (median age, 56 years; women, 61.9%) were included in the intention-to-screen analyses. Screening process completion was 38.4% in the colonoscopy outreach group, 28.0% in the FIT outreach group, and 10.7% in the usual care group. Compared with the usual care group, between-group differences for completion were higher for both outreach groups (27.7% [95% CI, 25.1% to 30.4%] for the colonoscopy outreach group; 17.3% [95% CI, 14.8% to 19.8%] for FIT outreach group), and highest in the colonoscopy outreach group (10.4% [95% CI, 7.8% to 13.1%] for the colonoscopy outreach group vs FIT outreach group; P < .001 for all comparisons). Compared with usual care, the between-group differences in adenoma and advanced neoplasia detection rates were higher for both outreach groups (colonoscopy outreach group: 10.3% [95% CI, 9.5% to 12.1%] for adenoma and 3.1% [95% CI, 2.0% to 4.1%] for advanced neoplasia, P < .001 for both comparisons; FIT outreach group: 1.3% [95% CI, -0.1% to 2.8%] for adenoma and 0.7% [95% CI, -0.2% to 1.6%] for advanced neoplasia, P < .08 and P < .13, respectively), and highest in the colonoscopy outreach group (colonoscopy outreach group vs FIT outreach group: 9.0% [95% CI, 7.3% to 10.7%] for adenoma and 2.4% [95% CI, 1.3% to 3.3%] for advanced neoplasia, P < .001 for both comparisons). There were no screening-related harms in any groups. CONCLUSIONS AND RELEVANCE: Among persons aged 50 to 64 years receiving primary care at a safety-net institution, mailed outreach invitations offering FIT or colonoscopy compared with usual care increased the proportion completing CRC screening process within 3 years. The rate of screening process completion was higher with colonoscopy than FIT outreach. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01710215.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Singal AG, Gupta S, Skinner CS, et al. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial. JAMA. 2017. PMID: 28873161. doi:10.1001/jama.2017.11389

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。